• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, August 21, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

FSU research sheds light on spinal cord injuries

Bioengineer by Bioengineer
January 21, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Study examines why so much damage occurs long after an accident

IMAGE

Credit: FSU Photography Services


TALLAHASSEE, Fla. — Thousands of people worldwide suffer severe spinal cord injuries each year, but little is known about why these injuries often continue to deteriorate long after the initial damage occurs.

Yi Ren, a professor of biomedical sciences at the Florida State University College of Medicine, is making progress in understanding why such significant harm is inflicted in the weeks and months after a spinal injury. In a study published today in the journal Nature Neuroscience, Ren explained how a natural immune system response may contribute to additional injury.

When spinal cord damage occurs, the endothelial cells that line blood vessels are activated to remove potentially harmful material, like myelin debris, from the site of the injury. However, Ren and her team discovered that this process may be responsible for causing further harm.

“The consequences of the effort of endothelial cells to clear myelin debris is often severe, contributing to post-traumatic degeneration of the spinal cord and to the functional disabilities often associated with spinal cord injuries,” said Ren, whose team conducted the study over a period of five years.

Myelin debris at the injury site comes from a shattering of the insulation protecting axons — the central nervous system’s primary transmission lines.

The inflamed area fills with macrophages, a type of white blood cell that engulfs foreign material and dead cells and is a key player in the immune response system. Macrophages remain in the area of the inflammation for months or even years. The mechanisms for macrophage infiltration remain unclear.

“Uncontrolled inflammation is one of the most important pathological events in the secondary injury cascade,” Ren said. “It persists for a long period of time following a spinal cord injury. We know that myelin debris acts as an inflammatory stimulus that exacerbates secondary injury by activating other cells in the injured spinal cord that are actively involved in inflammatory responses during disease progression.

“Clearing myelin debris generated at the time of injury is critical in controlling the inflammatory response and to ensuring neural regeneration.”

Little is known about the cellular and molecular mechanisms at work in clearing myelin debris from the injury site.

Ren’s lab demonstrated that debris can be engulfed by blood vessels and endothelial cells in the injured spinal cord. The problem is that once endothelial cells engulf the debris, they are enabled to promote inflammation and the formation of abnormal blood vessels. Those outcomes would inhibit the chances of a full recovery.

“Unexpectedly, we found that the process of engulfing debris confers upon endothelial cells the ability to stimulate production of fibrotic components suggesting that these cells have a function in the formation of fibrotic scars,” Ren said. “Specifically, they facilitate the arrival of macrophages derived from bone marrow that ultimately promote chronic inflammation.”

Ren said the same findings apply to the central nervous system damage inflicted by multiple sclerosis.

With a better understanding of the mechanisms at work, Ren hopes that researchers will find new ways for accident victims to regain lost functional ability without many of the unwanted side effects.

###

Media Contact
Doug Carlson
[email protected]
850-645-1255

Related Journal Article

http://dx.doi.org/10.1038/s41593-018-0324-9

Tags: Cell BiologyCritical Care/Emergency MedicineHealth CareMedicine/HealthneurobiologyNeurochemistryPainPhysiologyPublic HealthTrauma/Injury
Share12Tweet7Share2ShareShareShare1

Related Posts

blank

Combination Therapy Enhances Treatment Outcomes in Advanced Triple-Negative Breast Cancer

August 21, 2025
Ambient Documentation Technologies Alleviate Physician Burnout and Rekindle Joy in Medical Practice

Ambient Documentation Technologies Alleviate Physician Burnout and Rekindle Joy in Medical Practice

August 21, 2025

Decoding mTORC1’s Dynamic Amino Acid Control

August 21, 2025

Wearable Devices Improve Parkinson’s Medication Adjustments: Trial

August 21, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Celebrating 30 Years of Nanoimprint Lithography: Pioneering a New Era in Nanomanufacturing

Combination Therapy Enhances Treatment Outcomes in Advanced Triple-Negative Breast Cancer

Mount Sinai Researchers Develop First Targeted Therapy for Rare T-Cell Lymphoma Following CAR T Treatment

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.